These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7438675)

  • 21. Altered plasma half-lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunction.
    Vesell ES; Shapiro JR; Passananti T; Jorgensen H; Shively CA
    Clin Pharmacol Ther; 1975 Jan; 17(1):48-56. PubMed ID: 1122669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paracetamol pharmacokinetics in thyroid disease.
    Forfar JC; Pottage A; Toft AD; Irvine WJ; Clements JA; Prescott LF
    Eur J Clin Pharmacol; 1980 Oct; 18(3):269-73. PubMed ID: 7439247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of propranolol stereoisomers in hyperthyroid patients.
    Tawara K; Kawashima K; Ishikawa H; Yamamoto K; Saito K; Ebihara A; Yoshida S
    Eur J Clin Pharmacol; 1981 Feb; 19(3):197-203. PubMed ID: 6894282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of triiodothyronine (T3) kinetics in normal subjects, in hypothyroid, and hyperthyroid patients using specific antiserum for the determination of labeled T3 in plasma.
    Bianchi R; Zucchelli GC; Giannessi D; Pilo A; Mariani G; Carpi A; Toni MG
    J Clin Endocrinol Metab; 1978 Feb; 46(2):203-14. PubMed ID: 750602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma and urinary digoxin in thyroid dysfunction.
    Shenfield GM; Thompson J; Horn DB
    Eur J Clin Pharmacol; 1977 Dec; 12(6):437-43. PubMed ID: 598418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics and cardiac effects of propranolol in humans.
    Ochs HR; Grube E; Greenblatt DJ; Knüchel M; Bodem G
    Klin Wochenschr; 1982 May; 60(10):521-5. PubMed ID: 7098380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma cyclic AMP response to glucagon as an index of tissue responsiveness to thyroid hormone.
    Paisey R; Elkeles RS; Hambley J; Belchetz PE
    Diabete Metab; 1978 Dec; 4(4):267-70. PubMed ID: 215472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reference values for thyroid 24 hours 123I uptake].
    Aldighieri FC; Duarte PS; Alonso G
    Arq Bras Endocrinol Metabol; 2005 Jun; 49(3):425-32. PubMed ID: 16543998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of neuromedin B in control of the release of thyrotropin in hypothyroid and hyperthyroid rats.
    Rettori V; Pazos-Moura CC; Moura EG; Polak J; McCann SM
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3035-9. PubMed ID: 1557409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies.
    Sterle HA; Barreiro Arcos ML; Valli E; Paulazo MA; Méndez Huergo SP; Blidner AG; Cayrol F; Díaz Flaqué MC; Klecha AJ; Medina VA; Colombo L; Rabinovich GA; Cremaschi GA
    J Mol Med (Berl); 2016 Apr; 94(4):417-29. PubMed ID: 26564151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased clearance of propranolol in thyrotoxicosis.
    Feely J; Stevenson IH; Crooks J
    Ann Intern Med; 1981 Apr; 94(4 pt 1):472-4. PubMed ID: 7212504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenergic regulation of lipolysis in fat cells from hyperthyroid and hypothyroid patients.
    Wahrenberg H; Wennlund A; Arner P
    J Clin Endocrinol Metab; 1994 Apr; 78(4):898-903. PubMed ID: 8157718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hyperthyroidism and hypothyroidism on lipid and carbohydrate metabolism of the perfused rat liver.
    Laker ME; Mayes PA
    Biochem J; 1981 Apr; 196(1):247-55. PubMed ID: 7306071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereoselective clearance and distribution of intravenous propranolol.
    Olanoff LS; Walle T; Walle UK; Cowart TD; Gaffney TE
    Clin Pharmacol Ther; 1984 Jun; 35(6):755-61. PubMed ID: 6734027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic properties and bioavailability of methimazole.
    Jansson R; Lindström B; Dahlberg PA
    Clin Pharmacokinet; 1985; 10(5):443-50. PubMed ID: 4042519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zinc metabolism in thyroid disease.
    Nishi Y; Kawate R; Usui T
    Postgrad Med J; 1980 Dec; 56(662):833-7. PubMed ID: 7267493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma propranolol steady state concentrations in thyroid disorders.
    Feely J; Crooks J; Stevenson IH
    Eur J Clin Pharmacol; 1981; 19(5):329-33. PubMed ID: 7238561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic clearance and production rates of human thyrotropin.
    Ridgway EC; Weintraub BD; Maloof F
    J Clin Invest; 1974 Mar; 53(3):895-903. PubMed ID: 4812446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of thyroid function on the pharmacokinetics of gentamicin in pigs.
    Riond JL; Dix LP; Riviere JE
    Am J Vet Res; 1986 Oct; 47(10):2141-6. PubMed ID: 3777637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of food on the intravenous and oral dose kinetics of propranolol in the dog.
    Bai SA; Walle UK; Walle T
    J Pharmacokinet Biopharm; 1985 Jun; 13(3):229-41. PubMed ID: 4087163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.